Your browser doesn't support javascript.
loading
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.
Yin, Yibo; Boesteanu, Alina C; Binder, Zev A; Xu, Chong; Reid, Reiss A; Rodriguez, Jesse L; Cook, Danielle R; Thokala, Radhika; Blouch, Kristin; McGettigan-Croce, Bevin; Zhang, Logan; Konradt, Christoph; Cogdill, Alexandria P; Panjwani, M Kazim; Jiang, Shuguang; Migliorini, Denis; Dahmane, Nadia; Posey, Avery D; June, Carl H; Mason, Nicola J; Lin, Zhiguo; O'Rourke, Donald M; Johnson, Laura A.
Afiliação
  • Yin Y; The Fourth Section of Department of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
  • Boesteanu AC; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Binder ZA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Xu C; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Reid RA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Rodriguez JL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Cook DR; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA.
  • Thokala R; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Blouch K; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • McGettigan-Croce B; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Zhang L; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Konradt C; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Cogdill AP; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Panjwani MK; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Jiang S; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Migliorini D; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Dahmane N; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Posey AD; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • June CH; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA.
  • Mason NJ; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Lin Z; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • O'Rourke DM; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA.
  • Johnson LA; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA.
Mol Ther Oncolytics ; 11: 20-38, 2018 Dec 21.
Article em En | MEDLINE | ID: mdl-30306125

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China